<?xml version="1.0" encoding="UTF-8"?>
<p>
 <italic>Second</italic>, to have adequate preclinical tests that, either 
 <italic>in vitro</italic> or through adequate animal models, could deliver more clinically relevant information concerning distribution and pharmacological activity patterns and immunogenicity-related issues.
</p>
